Cell News and Research

RSS

Pacific Biosciences releases major upgrade to PacBio RS system

Pacific Biosciences of California, Inc., provider of Single Molecule Real Time sequencing products, today announced it has released a major upgrade to its PacBio RS system, referred to as "C2", including new chemistry, enhanced SMRT Cells and upgraded software, which together provide customers with significant performance increases for DNA sequencing.

13 Feb 2012

Scientists test new 'therapeutic vaccine' against HIV on volunteers

Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were so to say vaccinated with their own cells.

13 Feb 2012

Starving HIV virus could be the basis for future therapy: Study

In a medical breakthrough researchers at NYU Langone Medical Center and colleagues have shown how some cells in the body can repel attacks from HIV by starving the virus of the building blocks of life.

13 Feb 2012

Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

13 Feb 2012

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

Tenofovir associated with significant risk of kidney damage and chronic kidney disease

Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).

13 Feb 2012

Forbes examines how mobile phones are improving access to care in developing world

Mobile phones are improving access to health care in the developing world, according to the series "The Future of mHealth" by Mobiledia, a Forbes contributor.

13 Feb 2012

Discovery of novel rearrangements and fusions supports role for NGS in treatment of cancer

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute today announced the Nature Medicine publication of results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.

13 Feb 2012

EU-funded 4DCellFate project to kick off today

Today European scientists are meeting to kick off the 4DCellFate project, funded by the European Commission under the FP7 program.

13 Feb 2012

Elevated levels of cell-free fetal DNA early in pregnancy do not predict preeclampsia

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia.

13 Feb 2012

Risk of obstetric intervention lower for women who intended home births

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that the risk of obstetric intervention is lower for women who deliver or intend to deliver outside of hospitals, but there are some higher risks for newborns intended for home births compared to hospital births.

13 Feb 2012

Early MSC transplantation can help repair neonatal brain damage

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.

13 Feb 2012

OncoSec to commence OMS ElectroImmunotherapy Phase II trial in MCC

OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.

13 Feb 2012

SAMHD1 protein cuts off raw material that HIV needs to create DNA and replicate

A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.

13 Feb 2012

PORT may not prolong life in older people with NSCLC

Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.

13 Feb 2012

State roundup: Fraud crackdowns, searching for more doctors, immigrant health care

Illinois Democrats running state government have waited more than a year to win federal approval for a new plan to fight fraud in the health program for 2.7 million of the state's poorest residents. Facing increasing Republican pressure to put reforms in place, this week Quinn's team told the Obama administration that Illinois will wait no longer.

13 Feb 2012

SFU cell biologist to talk at AJAS conference on Feb. 16

Lynne Quarmby, a Simon Fraser University scientist with a passion for promoting the importance of science to life's sustenance, will have a captive audience during the world's largest science fair in Vancouver.

13 Feb 2012

Preterm birth interventions should be tailored for underlying risk factors and pathways

13 Feb 2012

Researchers discover a connection of peroxisomal protein import and receptor export

The group of Prof. Dr. Ralf Erdmann at the Ruhr-Universit-t Bochum discovered a connection of peroxisomal protein import and receptor export. In the Journal of Biological Chemistry, they disclosed that enzymes only get imported into certain cell organelles (peroxisomes) upon coupling of their import to the recycling of their transport protein.

13 Feb 2012

Researchers discover a startling feature of early brain development

Researchers at the Salk Institute have discovered a startling feature of early brain development that helps to explain how complex neuron wiring patterns are programmed using just a handful of critical genes. The findings, published February 3 in Cell, may help scientists develop new therapies for neurological disorders, such as amyotrophic lateral sclerosis (ALS), and provide insight into certain cancers.

13 Feb 2012

Cell News and Research

Pacific Biosciences releases major upgrade to PacBio RS system

Scientists test new 'therapeutic vaccine' against HIV on volunteers

Starving HIV virus could be the basis for future therapy: Study

Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs

InComm announces acquisition of Medagate

Tenofovir associated with significant risk of kidney damage and chronic kidney disease

Forbes examines how mobile phones are improving access to care in developing world

Discovery of novel rearrangements and fusions supports role for NGS in treatment of cancer

EU-funded 4DCellFate project to kick off today

Elevated levels of cell-free fetal DNA early in pregnancy do not predict preeclampsia

Risk of obstetric intervention lower for women who intended home births

Early MSC transplantation can help repair neonatal brain damage

OncoSec to commence OMS ElectroImmunotherapy Phase II trial in MCC

SAMHD1 protein cuts off raw material that HIV needs to create DNA and replicate

PORT may not prolong life in older people with NSCLC

State roundup: Fraud crackdowns, searching for more doctors, immigrant health care

SFU cell biologist to talk at AJAS conference on Feb. 16

Preterm birth interventions should be tailored for underlying risk factors and pathways

Researchers discover a connection of peroxisomal protein import and receptor export

Researchers discover a startling feature of early brain development

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News